Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06828562 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

GENomic Predictors in A Multi-Ethnic Population With Kidney Disease Study

Study acronym: Genie
StatusEnrolling by Invitation
PhaseNot specified
Started2025-02-10
View on ClinicalTrials.gov ↗

Amendment history

2025-07-14
Active, Not Recruiting→Enrolling by Invitation Study Status v2
Trial statusActive, Not Recruiting→Enrolling by Invitation
2025-02-16
Study Identification, Study Status, Sponsor/Collaborators, Eligibility v1
Eligibility criteria-305 characters
Inclusion Criteria: All participants included in the study must be age Age ≥ 18 years old at time of enrolment Able andto provide consent Either have kidney disease at anytime time,of enrolment or not have kidney disease but has at least one risk factorsfactor for kidney disease (eg family history, hypertension, diabetes, cardiac disease, obesity, smoking, kidney stones, regular nephrotoxin exposureuse) able to provide informed consent (healthcare interpreter permitted) for enrolment consentingConsent to longitudinal follow up (can withdraw postat enrolment) consentingConsent to provideprovidi [...] [...]
Study titlerevised
GENomic Predictors in aA Multi-Ethnic Population withWith Kidney Disease Study
2025-02-10
Original filing
To establish a prospective, longitudinal cohort of participants who can provide blood, tissue (including kidney histology), urine samples to establish a core biobank for kidney disease research. Results from this biobank will be matched to clinical outcomes to facilitate the discovery (and/or validation) of novel prognostic, predictive or diagnostic biomarkers important for kidney disease.
Trial Details
NCT Number NCT06828562
Lead Sponsor Western Sydney Local Health District
Conditions Kidney Disease
Enrollment 500 participants
Start Date 2025-02-10
Primary Completion 2040-01-01 (estimated)
Study Completion 2050-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-17